Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Patentability of Chemical Selection Inventions: The Olanzapine and Escitalopram Decisions - Hyewon Ahn

Patentability of Chemical Selection Inventions: The Olanzapine and Escitalopram Decisions

(Autor)

Buch | Softcover
76 Seiten
2011
Nomos (Verlag)
978-3-8329-6524-2 (ISBN)
CHF 30,80 inkl. MwSt
The thesis is a response to the recent decisions of the German Federal Court of Justice on the patentability requirements of selection inventions, namely, the Olanzapine and Escitalopram decisions.
This thesis provides an overview on the technology and patenting practice, followed by the discussion of jurisprudence on the patentability requirements for selection inventions in major jurisdictions. In particular, the paper examines the novelty and the non-obviousness requirements. As the discussion on the anticipation and obviousness is more contentious in selection inventions, this discusses the issues in view of the two decisions. Post grant impact of selection inventions and their meanings to the system of patent are explored, and some comparative perspectives on selection inventions are discussed.
In conclusion, by exploring the significance of granting patents on selection invention to the working of patent system, this paper aims to provide a useful analysis in understanding patentability requirements thereof, beyond the pharmaceutical industry sector.
The author researches on improvement patents in the field of pharmaceutical industry in Max-Planck Institute in Munich.
The thesis is a response to the recent decisions of the German Federal Court of Justice on the patentability requirements of selection inventions, namely, the Olanzapine and Escitalopram decisions. This thesis provides an overview on the technology and patenting practice, followed by the discussion of jurisprudence on the patentability requirements for selection inventions in major jurisdictions. In particular, the paper examines the novelty and the non-obviousness requirements. As the discussion on the anticipation and obviousness is more contentious in selection inventions, this discusses the issues in view of the two decisions. Post grant impact of selection inventions and their meanings to the system of patent are explored, and some comparative perspectives on selection inventions are discussed. In conclusion, by exploring the significance of granting patents on selection invention to the working of patent system, this paper aims to provide a useful analysis in understanding patentability requirements thereof, beyond the pharmaceutical industry sector.The author researches on improvement patents in the field of pharmaceutical industry at the Max-Planck Institute in Munich.
Erscheint lt. Verlag 22.7.2011
Reihe/Serie Munich Intellectual Property Law Center – MIPLC ; 12
Sprache englisch
Maße 153 x 227 mm
Gewicht 155 g
Themenwelt Recht / Steuern Wirtschaftsrecht Urheberrecht
Schlagworte Gewerblicher Rechtsschutz • Markenrecht • Patentrecht • Patentrecht (PatR) • Urheberrecht / Gewerblicher Rechtsschutz und Medie • Urheberrecht / Gewerblicher Rechtsschutz und Medienrecht
ISBN-10 3-8329-6524-6 / 3832965246
ISBN-13 978-3-8329-6524-2 / 9783832965242
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
und verwandte Schutzrechte

von Heinrich Hubmann; Manfred Rehbinder; Alexander Peukert

Buch | Softcover (2023)
C.H.Beck (Verlag)
CHF 48,85
Textausgabe zum deutschen, europäischen und internationalen Patent-, …
Buch | Softcover (2023)
dtv Verlagsgesellschaft
CHF 24,95